It is demonstrated that MAFF may play an important role in PD and provide insights into the molecular mechanisms of PD and may support the development of targeted therapeutic strategies.
Abstract
Background Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. Although MAFF may be involved in PD, the mechanisms underlying this association remain unclear. This study aimed to investigate the potential mechanisms of MAFF in PD and identify novel therapeutic targets. Methods PD-related datasets were obtained from public databases. The potential mechanisms of MAFF in PD were investigated using comprehensive gene expression profiling, receiver operating characteristic (ROC) analysis, Mendelian randomization (MR), functional enrichment analysis, immune infiltration analysis, drug prediction, molecular docking, and single-cell RNA sequencing (scRNA-seq). RT-qPCR and ELISA were then used to further validate MAFF expression in PD. Results MAFF was significantly upregulated in PD samples across multiple datasets and in both mouse and clinical samples. ELISA showed significantly increased MAFF expression in serum samples from patients with PD. The area under the curve (AUC) values for MAFF exceeded 0.70 in both datasets, indicating good diagnostic potential. MR analysis suggested a potential causal association between MAFF and PD (OR = 0.9075, 95% CI = 0.8243–0.9990, p = 0.0477). Notably, MAFF was significantly enriched in the MAPK signaling pathway, suggesting its potential involvement in regulating key cellular processes, including inflammation, in PD. In addition, two differentially infiltrating immune cell types were identified, and MAFF was positively correlated with monocytes. Diphenylcyclopropenone showed the highest interaction score with MAFF, and molecular docking indicated binding between MAFF and diphenylcyclopropenone, with a binding energy of −5.5 kcal/mol. Finally, scRNA-seq analysis highlighted the central roles of pericytes and endothelial cells in PD. Pseudotime analysis showed that MAFF was highly expressed during the late differentiation stages of endothelial cells. Conclusion Overall, this study demonstrated that MAFF may play an important role in PD. These findings provide insights into the molecular mechanisms of PD and may support the development of targeted therapeutic strategies.
This study integrates transcriptomic, genetic-causal, immunological, and structural analyses to prioritize STAT6 as a potentially druggable MS-associated target and strengthen the computational plausibility of STAT6-ligand interactions.
Zhongbo Xu, Ke Xiong, Dan Zhao· Computational biology and ch...· 0 citations
This exploratory study integrates pilot-scale metabolomics with genetic analyses to identify candidate metabolic signals and inflammatory pathways linked to PD and indicated that SULT1A1 may partially mediate the association between 3-phenylpropionylglycine and PD.
This study integrated bulk and single-cell transcriptomic datasets to identify PD-associated diagnostic candidate genes and explore their relationship with acupuncture-related temporal expression patterns, providing an integrative framework for prioritizing PD-associated candidate genes with exploratory acupuncture-rel...
Bing-Bing Zhao, Zhe Shi, Xiu-Ming Pang et al.· Frontiers in Aging Neuroscie...· 0 citations
Results support the view that ASE captures a broad regulatory signature in iPD, distinct from the DNA methylation context, and reinforces the role of immunogenetic dysregulation as a primary component of the disease's pathophysiology, offering new targets for mechanistic investigation and peripheral biomarkers.
R. M. Piergiorge, Alan Tardin da Silva, Ronaldo Francisco et al.· Computers in Biology and Med...· 0 citations
These findings provide the first independent evidence supporting the association between rare ITSN1 variants and PD in an East Asian population, extending previous discoveries from European cohorts.
Chun-Yu Li, R. Ou, Q. Wei et al.· Movement Disorders· 0 citations
Non-classical CD14+CD16+ monocytes were found to reduce the risk of PD, contrasting with findings from previous observational studies and providing new insights into the immune mechanisms underlying PD.
Yan Su, Sheng Cai, Yang Xu et al.· Clinics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.